Cargando…

Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease

[Image: see text] In the context of drug–receptor binding affinity calculations using molecular dynamics techniques, we implemented a combination of Hamiltonian replica exchange (HREM) and a novel nonequilibrium alchemical methodology, called virtual double-system single-box, with increased accuracy...

Descripción completa

Detalles Bibliográficos
Autores principales: Macchiagodena, Marina, Pagliai, Marco, Karrenbrock, Maurice, Guarnieri, Guido, Iannone, Francesco, Procacci, Piero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015232/
https://www.ncbi.nlm.nih.gov/pubmed/33090785
http://dx.doi.org/10.1021/acs.jctc.0c00634
_version_ 1783673639755841536
author Macchiagodena, Marina
Pagliai, Marco
Karrenbrock, Maurice
Guarnieri, Guido
Iannone, Francesco
Procacci, Piero
author_facet Macchiagodena, Marina
Pagliai, Marco
Karrenbrock, Maurice
Guarnieri, Guido
Iannone, Francesco
Procacci, Piero
author_sort Macchiagodena, Marina
collection PubMed
description [Image: see text] In the context of drug–receptor binding affinity calculations using molecular dynamics techniques, we implemented a combination of Hamiltonian replica exchange (HREM) and a novel nonequilibrium alchemical methodology, called virtual double-system single-box, with increased accuracy, precision, and efficiency with respect to the standard nonequilibrium approaches. The method has been applied for the determination of absolute binding free energies of 16 newly designed noncovalent ligands of the main protease (3CL(pro)) of SARS-CoV-2. The core structures of 3CL(pro) ligands were previously identified using a multimodal structure-based ligand design in combination with docking techniques. The calculated binding free energies for four additional ligands with known activity (either for SARS-CoV or SARS-CoV-2 main protease) are also reported. The nature of binding in the 3CL(pro) active site and the involved residues besides the CYS–HYS catalytic dyad have been thoroughly characterized by enhanced sampling simulations of the bound state. We have identified several noncongeneric compounds with predicted low micromolar activity for 3CL(pro) inhibition, which may constitute possible lead compounds for the development of antiviral agents in Covid-19 treatment.
format Online
Article
Text
id pubmed-8015232
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-80152322021-04-02 Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease Macchiagodena, Marina Pagliai, Marco Karrenbrock, Maurice Guarnieri, Guido Iannone, Francesco Procacci, Piero J Chem Theory Comput [Image: see text] In the context of drug–receptor binding affinity calculations using molecular dynamics techniques, we implemented a combination of Hamiltonian replica exchange (HREM) and a novel nonequilibrium alchemical methodology, called virtual double-system single-box, with increased accuracy, precision, and efficiency with respect to the standard nonequilibrium approaches. The method has been applied for the determination of absolute binding free energies of 16 newly designed noncovalent ligands of the main protease (3CL(pro)) of SARS-CoV-2. The core structures of 3CL(pro) ligands were previously identified using a multimodal structure-based ligand design in combination with docking techniques. The calculated binding free energies for four additional ligands with known activity (either for SARS-CoV or SARS-CoV-2 main protease) are also reported. The nature of binding in the 3CL(pro) active site and the involved residues besides the CYS–HYS catalytic dyad have been thoroughly characterized by enhanced sampling simulations of the bound state. We have identified several noncongeneric compounds with predicted low micromolar activity for 3CL(pro) inhibition, which may constitute possible lead compounds for the development of antiviral agents in Covid-19 treatment. American Chemical Society 2020-10-22 2020-11-10 /pmc/articles/PMC8015232/ /pubmed/33090785 http://dx.doi.org/10.1021/acs.jctc.0c00634 Text en © 2020 American Chemical Society Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Macchiagodena, Marina
Pagliai, Marco
Karrenbrock, Maurice
Guarnieri, Guido
Iannone, Francesco
Procacci, Piero
Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease
title Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease
title_full Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease
title_fullStr Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease
title_full_unstemmed Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease
title_short Virtual Double-System Single-Box: A Nonequilibrium Alchemical Technique for Absolute Binding Free Energy Calculations: Application to Ligands of the SARS-CoV-2 Main Protease
title_sort virtual double-system single-box: a nonequilibrium alchemical technique for absolute binding free energy calculations: application to ligands of the sars-cov-2 main protease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015232/
https://www.ncbi.nlm.nih.gov/pubmed/33090785
http://dx.doi.org/10.1021/acs.jctc.0c00634
work_keys_str_mv AT macchiagodenamarina virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease
AT pagliaimarco virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease
AT karrenbrockmaurice virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease
AT guarnieriguido virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease
AT iannonefrancesco virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease
AT procaccipiero virtualdoublesystemsingleboxanonequilibriumalchemicaltechniqueforabsolutebindingfreeenergycalculationsapplicationtoligandsofthesarscov2mainprotease